Cardiovascular disease

Read our publications related to this topic.

Journal Articles

16/03/2026

Hydralazine use and risk of vasculitis

Fremont D, Dhaliwal S, Canney M, Akbari A, Hundemer GL, Derebail VK, Sood MM, Massicotte-Azarniouch D. JAMA Netw Open. 2026; 9(3): e261943.

Journal Article

09/03/2026

Long-term risk of major coronary artery disease events after thrombotic microangiopathy treated with plasma exchange

Jamison HK, Bota SE, Garg AX, Kang Y, McArthur E, Huang SS, Clark WF, Sontrop JM, Eberhart AM. Am J Hematol. 2026; Mar 9 [Epub ahead of print].

Journal Article

09/03/2026

Risks of thrombosis and hemorrhage in concurrent use of anticoagulants and potential interacting prostate cancer agents

Wang TF, Clarke A, Rath M, Yoo S, Fremont D, Wu C, Ravani P, Bossé D, Talarico R, Carrier M, Sood MM. Cancer. 2026; 132(6):e70266.

Journal Article

04/03/2026

An artificial intelligence prediction model for optimizing patient selection for cardiac imaging for the investigation of suspected coronary artery disease

Petch J, Di S, Watson T, Becerra MP, Rosella LC, Natarajan MK, Sheth T, Schwalm JD. Eur Heart J Digit Health. 2026; 7(3): ztag040.

Journal Article

25/02/2026

Impact of wait-times for atrial fibrillation ablation on cumulative healthcare costs

Qeska D, Qiu F, Manoragavan Mma R, Abdel-Qadir H, Cheung CC, Ko DT, Singh SM, Sud MK, Wijeysundera HC. Heart Rhythm. 2026; S1547-5271(26)00154-2. Epub 2026 Feb 25.

Journal Article

03/02/2026

Hemoglobin concentration in early pregnancy and severe neonatal morbidity and mortality: population-based cohort study

Shams I, Tang GH, Wang X, Walker M, Baxter NN, Gomes T, Ray JG, Sholzberg M. Ann Intern Med. 2026; Feb 3 [Epub ahead of print].

Journal Article

27/01/2026

Impact of depression on TAVR wait time and post-TAVR outcomes: a population-based study

Abu Ghosh Z, Qiu F, Manoragavan R, Tam DY, Ko DT, Wijeysundera HC, Sud M. Eur Heart J Open. 2026; 6(1): oeag010.

Journal Article

13/01/2026

Patterns and outcomes of completeness of revascularization in patients with diabetes and non-ST-segment-elevation myocardial infarction in Ontario, Canada

Godoy LC, Farkouh ME, Austin PC, Shah BR, Qiu F, Sud M, Nicolau JC, Razzouk L, Fremes SE, Lawler PR, Gaudino MFL, Ko DT. Circ Popul Health Outcomes. 2026; 19(2): e012310. Epub 2026 Jan 13.

Journal Article

08/12/2025

Time-varying comparative effectiveness of surgical or percutaneous revascularization on patient-centred outcomes

Fielding-Singh V, O’Donnell C, Boyd JH, Tuna M, Mamas MA, Ruel M, Sun LY. CMAJ. 2025; 197(42): E1436-E1448.

Journal Article

25/11/2025

Women with chronic coronary artery disease: long-term outcomes after percutaneous coronary intervention vs coronary artery bypass grafting

An KR, Vervoort D, Qiu F, Tam DY, Rocha RV, Harik L, Hirji S, Sandner S, Fremes SE, Wijeysundera HC, Gaudino MFL. Eur Heart J. 2025; Nov 25 [Epub ahead of print].

See All

News Releases

News Release

14/05/2025

Coordinated primary, palliative, and specialty care improve outcomes for organ failure patients at end of life, studies show

News Release

08/10/2024

75% of people with heart failure die in hospital, researchers find providing end-of-life care doubles likelihood of dying at home

News Release

28/01/2020

New drug containing an omega-3 fatty acid found in fish oil may help one in four high-risk patients avoid heart attacks and strokes

See All

Research Programs and appointed ICES Scientists

ICES scientists are appointed to the ICES Research Program which best fits their interests and, as such, become members of a network of health services researchers from across Ontario.

ICES Scientists Research Programs

Cardiovascular disease

Journal Articles

Hydralazine use and risk of vasculitis

Long-term risk of major coronary artery disease events after thrombotic microangiopathy treated with plasma exchange

Risks of thrombosis and hemorrhage in concurrent use of anticoagulants and potential interacting prostate cancer agents

An artificial intelligence prediction model for optimizing patient selection for cardiac imaging for the investigation of suspected coronary artery disease

Impact of wait-times for atrial fibrillation ablation on cumulative healthcare costs

Hemoglobin concentration in early pregnancy and severe neonatal morbidity and mortality: population-based cohort study

Impact of depression on TAVR wait time and post-TAVR outcomes: a population-based study

Patterns and outcomes of completeness of revascularization in patients with diabetes and non-ST-segment-elevation myocardial infarction in Ontario, Canada

Time-varying comparative effectiveness of surgical or percutaneous revascularization on patient-centred outcomes

Women with chronic coronary artery disease: long-term outcomes after percutaneous coronary intervention vs coronary artery bypass grafting

News Releases

Coordinated primary, palliative, and specialty care improve outcomes for organ failure patients at end of life, studies show

New online calculator predicts risk of developing heart disease

Women with heart attacks are less likely to receive crucial therapies and have higher mortality than men

New research highlights stroke care disparities in vulnerable communities

Decision support tool used in the emergency department reduces rates of death or hospitalization after heart failure

75% of people with heart failure die in hospital, researchers find providing end-of-life care doubles likelihood of dying at home

More women than men are admitted to nursing homes after suffering a stroke and they have higher care needs

Prescribing anticoagulants in the ED for atrial fibrillation increases long-term use by 30%

Ontario doctors have better heart health than the general public

New drug containing an omega-3 fatty acid found in fish oil may help one in four high-risk patients avoid heart attacks and strokes

Research Programs and appointed ICES Scientists